Bridging Mitochondria, Microbiota and Precision Medicine
Welcome to the Third World Congress on Targeting Extracellular Vesicles 2026
It is with great pleasure that we welcome you to Targeting Extracellular Vesicles 2026, to be held on November 12–13, 2026 in Porto, Portugal.
Following the strong scientific momentum of previous editions, the spirit of Targeting EVs continues: to explore extracellular vesicles not as isolated entities, but as central drivers of biological communication, adaptation, and dynamic medicine. Read More
Targeting EV's 2026 Agenda
EXTRACELLULAR VESICLES: Bridging Mitochondria, Microbiota and Precision medicine
Key Dates
Targeting EV's 2026 Confirmed Speakers
Engineered EV for Precision Targeting and Nucleic Acid Delivery: From Mechanistic Insights to Therapeutic Applications
Pieter Vader, Utrecht University, The Netherlands
Glial EVs as Guardians of Axonal Mitochondria: Linking Neurobiology, Stress, and Inflammaging
Eva-Maria Krämer-Albers, Johannes Gutenberg University of Mainz, Germany
A New Perspective on the Role of Mitovesicles, Small Mitochondria-Derived Extracellular Vesicles, in Alzheimer’s Disease
Efrat Levy, New York University Grossman School of Medicine, USA
Bacterial Membrane Vesicles as Carriers of Bioactive Compounds
Leo Eberl, University of Zurich, Switzerland
Senescence Modulation Through EVs
Lino Ferreira, CNC-UC, University of Coimbra, Portugal
Can We Program EV Tropism? Lessons from Brain-Targeted Exosome Delivery to Next-Generation RNA Medicines.
Dhanu Gupta, University of Oxford, United Kingdom
Lipids in EVs: Membrane Constituents and Regulators of their Biogenesis and Release
Alicia Llorente, Oslo University Hospital, Norway
Bacterial Extracellular Vesicles Restore Immune Balance in Gut-First Parkinson’s Disease
Sandra Morais Cardoso, CNC-UC, University of Coimbra, Portugal
Platelet-Derived Microvesicles as Mitochondrial Messengers: Reprogramming Immune Bioenergetics and Inflammation
Luc Boudreau, University of Moncton, Canada
Redox Regulation of Extracellular Vesicle Communication
Carla Lopes, University of Minho, Portugal
Extracellular Vesicles in Cardiometabolic Medicine: Biomarkers, Mechanisms, and Therapies
Ramaroson Andriantsitohaina, Université de Montpellier, France
Hybrid EV-Based Platforms for Retinal mRNA Delivery
Elita Montanari, Università degli studi Roma Tre, Italy
Surface Functionalization and Tissue Tropism
Kuldeep Neote, Diadem Biotherapeutics, USA
Platelet-Derived Microvesicles as Growth Factor Platforms: Reprogramming Cancer Cell Signaling and the Tumor Microenvironment
Gilles A. Robichaud, Université de Moncton, Canada
GMP Manufacturing and Scalability Solutions in your Advertisement Materials
Andreia M. Silva, Exogenus Therapeutics, S.A., Portugal
Mitochondrial Signaling Beyond the Organelle: EVs-Mediated Neuroinflammation in Brain Injury
Bartosz Szczesny, The University of Texas Medical Branch, USA
Clinical Potential of MSC-EVs and Translational Challenges
Bernd Giebel, University Hospital Essen, Germany
Can Plasma EVs Carry Rejuvenation Signals? Age-Dependent Control of Inflammation and Oxidative Stress.
Raghavan Pillai Raju, Augusta University, USA
Who is Attending Targeting Extracellular Vesicles 2026
AMOEBA, France
Augusta University, USA
Beiersdorf AG, Germany
BIOCODEX, France
Biotechnology Research Center, Algeria
Bonexis s.r.o., Czech Republic
CIBERNED, Spain
Dél-pesti Centrumkórház – Országos Hematológiai és Infektológiai Intézet, Hungary
Diadem Biotherapeutics, USA
Exogenus Therapeutics, S.A., Portugal
Heinrich Heine University Düsseldorf, Germany
IHMT – NOVA, Portugal
IMC Hochschule für Angewandte Wissenschaften Krems GmbH, Austria
Institut Imagine, France
Institute of Biotechnology, CAS v.v.i., Czech Republic
Jagiellonian University, Poland
Johannes Gutenberg University of Mainz, Germany
Lithuanian University of Health Sciences, Lithuania
LMU München, Germany
L’Oréal, France
Maastricht University, Netherlands
Medical University of Gdańsk, Poland
Midwestern University, USA
New York University Grossman School of Medicine, USA
Örebro University, Sweden
Orthopedic Associates of Long Island, USA
Oslo Metropolitan University, Norway
Shree Shodashi Therapeutics Private Limited, India
Symrise Srl, Italy
Thiogenesis Therapeutics, France
Umeå University, Sweden
Université de Moncton, Canada
Université Paris-Saclay, INRAE, AgroParisTech, MICALIS, France
Università degli Studi Roma Tre, Italy
University of Coimbra, Portugal
University of Groningen, Netherlands
University of Innsbruck, Austria
University of Liège – Faculty of Veterinary Medicine, Belgium
University of Milan, Italy
University of Minho, Portugal
University of Montpellier, France
University of Namur, Namur Research Institute for Life Sciences (NARILIS), Belgium
University of Nebraska Medical Center, USA
University of Oulu, Finland
University of Oxford, UK
University of Paris, Portugal [country to confirm]
University of Porto, Portugal
University of Sheffield, UK
University of Texas Health San Antonio, USA
University of Texas Medical Branch, USA
University of Valencia, Spain
University of Zurich, Switzerland
Utrecht University, Netherlands
Vall d’Hebron Research Institute (VHIR), Spain
Last updated on Oct 6
The Preliminary Agenda & Speakers Are Now Live!
Targeting Exosome 2026 Will Be Held at Hilton Porto Gaia, Portugal
A Landmark Reference for the EV and Exosome Community : Extracellular Mitochondria in Health and Disease Book by Carla Lopes
Scientific Contribution Award 2025 decerned to Carla Lopes
Best Oral Presentation Award 2025 decerned to Javier Huete Acevedo
Can Bacterial Vesicles Talk to Our Mitochondria?
Beyond Exosomes: Neurons May Communicate with Microglia Using DNA Fragments
Exercise Does More Than Move Muscles It Moves Mitochondria
The Microbiome Revolution: Personalized Therapies for Tomorrow
Emerging therapeutic role of gut microbial extracellular vesicles in neurological disorders
